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Optimal target vessel stenosis
for radial artery grafting
To the Editor:
The article by Bleiziffer and colleagues1 is
the latest in a growing body of literature2-6
reporting worse radial artery graft patency
when anastomosed to coronary targets
with moderate disease (eg, 70%–90% steno-
sis) compared with targets with severe
stenosis (.90% stenosis). This finding is
highly reproducible, as evidenced by analy-
ses of both retrospectively2-5 and pros-
pectively1,6 collected angiographic data
reported by multiple authors at multiple
institutions spanning multiple continents.
Arguably, the convergence of the published
literature to the same target stenosis–radial
patency relationship coupled with the avail-
able objective mechanistic explanation
(competitive flow) for this finding should
put this question to rest. More specifically,
when one is faced with the choice, radial
artery grafts should be preferentially anasto-
mosed to the most severely diseased coro-
nary targets (.90% stenosis). These
studies, however, have not objectively ad-
dressed the question of which conduit type
(vein vs radial) should be used for coronary
targets with less severe disease (eg, ,90%
stenosis). Yet, in their article, Bleiziffer
and coworkers concluded the following:
‘‘On the basis of our results, we attempt to
use the radial artery only for target coronary
arteries with 90% or greater stenosis.’’ I con-
tend that the graft patency data presented to
date by these authors and others2-6 do not
justify such a limitation on radial artery
grafting, and that such a position represents
a case of over-concluding. More specifi-
cally, some (perhaps including the authors1)
may extrapolate this conclusion, which is
based only on data for radial artery patency,
to suggest that saphenous vein grafts would
then be superior to radial artery grafts when
placed in coronary targets with less than
90% disease. I am unaware of any such
data. To the contrary, in their most recent re-
port, Desai and colleagues7 analyzed pro-
spectively collected radial and vein graft
patency data and reported the following: 1)
Radial patency increases with increased tar-
get stenosis; 2) vein patency does not vary
with target stenosis; and, most important,
3) radial patency is superior to that of vein
patency when placed in both moderately
and severely diseased coronary targets.
These data indicate that the radial artery
should be preferred to the vein even for
moderately diseased coronary targets, a con-
clusion that contradicts the authors’ recom-
mendation in this article.1
Robert H. Habib, PhD
Cardiovascular and Pulmonary Research
Yvonne Viens, SGM, Research Institute
St Vincent Mercy Medical Center
Toledo, Ohio
Department of Surgery
University of Toledo College of Medicine
Toledo, Ohio
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Reply to the Editor:
We fully agree with Habib that, on the basis
of the current literature, radial artery patency
is supposed to be superior to sapheneous
vein patency even when the grafts are anas-
tomosed to moderately stenosed coronary
targets. Nevertheless, we believe that the ra-
dial artery as a graft for coronary artery by-
pass grafting should be used under the most
promising conditions, that is, for highly
stenosed coronary vessels. Radial artery
harvesting is more complex than vein har-
vesting and may lead to more serious com-
plications, such as circulatory or sensory
disturbances at the donor arm. Considering
this in a risk–benefit analysis, we argue
that the radial artery should be harvested
only when optimum patency rates are ex-
pected for the individual patient. Therefore,
we adhere to our recommendation to place
the radial artery only to highly stenosed
target vessels.
Sabine Bleiziffer, MD
Ruediger Lange, PhD, MD
Clinic for Cardiovascular Surgery
German Heart Center Munich
Munich, Germany
doi:10.1016/j.jtcvs.2007.10.016
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Letters to the EditorProlonged mechanical
ventilation after cardiovascular
surgery
To the Editor:
I read with great interest the excellent article
by Dr Murthy and colleagues1 describing
prolonged ventilatory dependence after car-
diovascular surgery. The following clinical
questions have arisen since my review of
this study:
1. What are the possible explanations
for the significant decrease in venti-
latory dependence over time? What
major changes in delivery of care
occurred during the study period
(1998–2001)?
2. What was aprotinin exposure in the
study cohort? What are the possible
ways aprotinin exposure affected
the study results? Aprotinin has
been associated with a tendency to
reduced ventilation time and reduced
pulmonary complications after tho-
racic aortic surgery.2 Furthermore,
in meta-analysis, aprotinin was the
only antifibrinolytic associated with
a significantly decreased rate of re-
operation for bleeding.3 Both aortic
surgery and reoperation for bleeding
were significant predictors for venti-
latory dependence in your published
study.
3. Were there any major changes in
anesthetic techniques during the
study period that may have
affected the incidence of ventilatory
dependence?lar Surgery c Volume 135, Number 2 463
protection over the years and a progressive
increase of intraoperative echocardiography
use; these factors likely promote more rapid
myocardial recovery. Less narcotics are be-
ing given intraoperatively, and this may fa-
cilitate earlier separation from mechanical
ventilatory support. In addition, there has
been a noticeable increase in intensivist
staffing, such that there is seemingly more
planning and continuity of care in the inten-
sive care unit, which again, might favorably
affect weaning.
Second, aprotinin is used sparingly at
our institution (in ,1% of patients). This
is, in part, secondary to cost, but also for
concerns regarding thrombotic complica-
tion and renal dysfunction, all without
clearly demonstrable benefit. There are 2
populations for whom we do use aprotinin
on more occasions: patients with ventricu-
lar-assist devices and patients undergoing
a second cardiac transplant. These groups
were excluded from our study.
Sudish C. Murthy, MD, PhD
Thoracic and Cardiovascular Surgery
The Cleveland Clinic
Cleveland, Ohio
doi:10.1016/j.jtcvs.2007.10.025
clinical outcomes, and at which degree of
severity and in which categories of patients
this impact of PPM becomes statistically
significant and clinically relevant. Unfortu-
nately, the data provided by Totaro and
Argano1 do not permit an answer to these
important questions.
There are serious concerns about the val-
idity of the Doppler echocardiographic data,
and especially of those of the valve EOA.
This is a crucial aspect, because the identifi-
cation and quantification of PPM are based
on these data. First, it is intriguing to see
that the EOAs measured in vivo by Doppler
echocardiography, especially for the 25- and
27-mm valves, were larger than the EOAs
measured in vitro by the manufacturer. A re-
cent study has indeed demonstrated that, as
opposed to the observation in this study, the
in vitro EOAs provided by the manufacturer
grossly overestimate the in vivo EOAs and
are thus not valid for prediction of PPM.6
Totaro and Argano also used the label pros-
thesis size as a surrogate for PPM, whereas
previous studies have shown that this
parameter is not valid for identification of
PPM and prediction of its hemodynamic
and clinical consequences.3,6,7
Moreover, the huge variability in the
Letters to the EditorI congratulate the authors again on
a most thought-provoking study. I look
forward to their feedback about these con-
siderations.
John G. T. Augoustides, MD, FASE
Department of Anesthesiology and Critical Care
Hospital of the University of Pennsylvania
Philadelphia, PA 19104-4283
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We appreciate the comments provided by Dr
Augoustides in regard to our recent article
‘‘Ventilatory Dependency After Cardiovas-
cular Surgery.’’ Our article attempts to de-
fine the risks for ventilator dependency and
determine the outcomes of patients who de-
velop this problem after their index cardio-
vascular surgery. Two inquiries were made
(as points [a] and [c] are closely related).
We were surprised ourselves to find that
there has been a continuing trend toward
a lower prevalence of ventilator dependency
at our institute. A declining trend was noted
in previous studies from our institute pub-
lished several years before. That this trend
has continued through the current study
has both thrilled and perplexed us. It was im-
possible for us to determine which quantifi-
able variables might be responsible for this
trend because of a variety of confounding
factors, not the least of which is time itself.
What is even more interesting is that this
phenomenon has occurred in the setting of
increasing complexity and acuity of illness.
It is our suspicion that several coincident
changes might be responsible. There has
been a steady improvement in myocardial
Prosthesis–patient mismatch
after mitral valve replacement:
Back to reality
To the Editor:
We read with interest the article of Totaro
and Argano.1 We have, however, several
concerns with regard to the validity of the
results and conclusions presented in this
article. First, the title of the article, ‘‘Pa-
tient–Prosthesis Mismatch after Mitral
Valve Replacement: Myth or Reality?’’ is
inappropriate. Mitral prosthesis–patient
mismatch (PPM) is equivalent to a residual
mitral stenosis, related to the fact that most
prosthetic valves have a hemodynamic per-
formance, and thus a valve effective orifice
area (EOA), that is inferior to that of the nor-
mal native valve. Thus concluding that PPM
is a myth would be equivalent to saying that
mitral stenosis (or aortic stenosis for aortic
PPM) does not exist, and that this is a benign
phenomenon, which is of course not the
case. In this regard, several studies have
demonstrated that PPM is a frequent hemo-
dynamic phenomenon after mitral or aortic
valve replacement.2-5 The important ques-
tion is rather to determine the impact of
PPM on the hemodynamic, functional, and
EOA measurements for a given prosthesis
size (from 1.0 to 4.9 cm2 for the 29-mm pros-
theses!), the complete absence of correlation
between the EOA and the transprosthetic gra-
dient, and the recording of high transpros-
thetic gradients (.15 mm Hg) in several
patients despite the calculation of large
EOAs and indexed EOAs (see Figure 3 of
the article1) further support the concerns
regarding the validity of the EOA measure-
ments and thus the identification of PPM.
The presence of gradients greater than 15
mm Hg in the mitral position definitely
cannot be considered as ‘‘favorable hemody-
namics,’’ as concluded by Totaro and
Argano.1 In fine, these observations suggest
that a large proportion of the patients in-
cluded in this series were misclassified with
respect to the presence or absence of PPM.
Totaro and Argano only measured the
valve hemodynamics and systolic pulmo-
nary arterial pressure at predischarge exam-
ination or at 30 days. It is well known that
the measurements of valve EOA, transvalv-
ular gradients, and pulmonary pressure in
the early postoperative period are often
unreliable because of the poor acoustic win-
dow, hyperdynamic state, or flow accelera-
tion in the left ventricular outflow tract.
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